KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth Atsushi Yamamoto, Masaru Kamishohara, et al. Mol Cancer Ther 2004;3:1639-1649
The pharmacological and toxicological properties of this product have not been fully investigated. Exercise caution in use and handling. This product must not be used in humans.